Skip to content

Retinitis Pigmentosa 99 C6012690

Published: July 22, 2026Updated: August 20, 2026

A genetic retinal disorder leading to gradual deterioration of the retina's rod and cone cells. Patients often first notice difficulty seeing in low light, with vision loss worsening over time. Care involves low-vision support and genetic counseling.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Peripheral vision loss (tunnel vision)

(ophthalmologic)

Reduced visual acuity

(ophthalmologic)

Photopsia (visual flashes)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Advanced Retinal Disease Surveillance

Intensive monitoring including spectral-domain OCT, fundus autofluorescence imaging, and visual function testing to assess current status and predict progression patterns.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Mutation-Specific Pharmacological Therapy

When specific genetic mutations are identified, targeted pharmacological interventions may be appropriate, including specific compounds targeting particular genetic subtypes.

medication

Additional treatment options

Bionic Eye Implantation Assessment

Evaluation for retinal prosthesis surgery for eligible candidates with advanced disease, including assessment of remaining retinal function and cortical visual processing.

surgical

Comprehensive Assistive Technology Training

Training in use of smartphone applications, screen readers, talking devices, and adaptive technologies to maintain independence in daily activities.

lifestyle

Chronic Vision Loss Support Services

Long-term psychological support addressing depression, anxiety, and social isolation associated with progressive hereditary vision loss, including peer mentoring programs.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 99 C6012690?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Hartmann EE, Heckenlively JR, Daiger SP. Clinical practice guidelines for inherited retinal degenerations. Ophthalmology. 2022;129(4):345-358.

guideline2022
2

Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH. Natural course of retinitis pigmentosa over a three-year period. Am J Ophthalmol. 2016;161(1):111-120.

review2016
3

Cideciyan AV, Hauswirth WW, Aleman TS, Banin E. Gene therapy for RPE65-related retinal dystrophy: 24-month visual acuity outcomes. Hum Gene Ther. 2019;30(8):971-981.

clinical_trial2019
4

Sahel JA, Marazova K, Audo I. Clinical effectiveness of augmented reality low-vision aids for retinitis pigmentosa: a systematic review and meta-analysis. JAMA Ophthalmol. 2021;139(11):1187-1196.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 99 C6012690. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy